Pharmacists are moving beyond order verification into patient education, adverse effect mitigation, and parts of toxicity ...

Meta-analysis suggests off-label upadacitinib drives major alopecia areata hair regrowth and SALT score gains, but phase 3 ...

Pamala A. Pawloski, PharmD, outlines barriers to precision medicine adoption at AMCP Nexus 2026, calling for standardization ...

Experts at ASN Kidney Week say earlier detection, national CKD screening, and faster uptake are needed to bring new therapies ...

Elagolix 150 mg was noninferior to dienogest 2 mg for reducing moderate-to-severe endometriosis pain in a phase 3 trial of ...

Norah Terrault, MD, MPH, on why few diagnosed patients reach HCV cure and how primary care test-and-treat can close the gap.

Initial frontal fibrosing alopecia treatment was largely similar in Black and White patients, though tetracycline use was ...

An analysis of AccessHope case reviews found that experts recommended changes in more than 80% of cases. About half were ...

About half of patients with chronic hepatitis B or C also had MASLD, which tracked with worse fatigue and quality of life.

From taladegib to admilparant and inhaled treprostinil, here are the key 2026 advances in idiopathic pulmonary fibrosis care.

Patients with generalized myasthenia gravis who responded best to efgartigimod were not the ones with the biggest drop in ...

HHS enforcement discretion lets state pharmacies compound BPC-157 and other peptides amid rulemaking and legal challenges.